ECM
MBIO icon

Endurant Capital Management’s Mustang Bio MBIO Stock Holding History

Endurant Capital Management’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,189
Closed -$3.38M – 66
2020
Q4 		$3.38M Sell
1,189
-708
-37% -$1.69M 1.22% 29
2020
Q3 		$4.48M Buy
1,897
+872
+85% +$2.15M 1.33% 27
2020
Q2 		$2.44M Buy
+1,025
New +$2.4M 0.13% 36

Other funds holding MBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Endurant Capital Management's MBIO Position: Q1 2021 in Review

Endurant Capital Management sold out of Mustang Bio (MBIO) in Q1 2021, closing a stake of 1,189 shares — an estimated $3.38M sold.

Endurant Capital Management first reported a position in MBIO in Q2 2020 and held it in 3 quarters. The position peaked at $4.48M in Q3 2020. 95 funds tracked by Wall St. Rank hold MBIO as of Q1 2021.

  • Endurant Capital Management reported no remaining Mustang Bio position as of Q1 2021 after selling out during the quarter.
  • Endurant Capital Management sold 1,189 Mustang Bio shares in Q1 2021, an estimated $3.38M.
  • Endurant Capital Management first reported a position in Mustang Bio in Q2 2020 and held it in 3 quarters.
  • Endurant Capital Management's Mustang Bio position peaked at $4.48M in Q3 2020.
  • 95 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2021.

Based on Endurant Capital Management's 13F filing for Q1 2021, filed 17 May 2021.